Development of Monoclonal Antibody LpMab-10 Recognizing Non-Glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy - United States
doi 10.1089/mab.2015.0018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
AllergyImmunology
2015English

Epitope Mapping of Monoclonal Antibody PMab-52 Against Cat Podoplanin

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
AllergyImmunology
2018English

Epitope Mapping of Monoclonal Antibody PMab-48 Against Dog Podoplanin

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
AllergyImmunology
2018English

LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin

PLoS ONE
Multidisciplinary
2016English

Monoclonal Antibody EMR1a/212D Recognizing Extracellular Regions With Lipid-Deposits

The Journal of Japan Atherosclerosis Society
1987English

Establishment of Anti-Horse Podoplanin Monoclonal Antibody Using Cell-Based Immunization and Screening (CBIS) Method

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Characterization of a Monoclonal Antibody to Human Erythropoietin.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Monoclonal Antibody Therapy for Non-Malignant Disease

Australian Prescriber
Pharmacology
2006English

Intracellular Neutralization of Shiga Toxin 2 by an a Subunit-Specific Human Monoclonal Antibody

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy